Mimedx (MDXG) Equity Average (2011 - 2026)

Mimedx has disclosed Equity Average across 16 years of filings, most recently posting $249.7 million for Q1 2026.

• Equity Average for Q1 2026 came in at $249.7 million, up 26.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $249.7 million (up 26.17% YoY), and the FY2025 annual result was $224.8 million, up 33.9% from the prior year.
• Equity Average came in at $249.7 million for Q1 2026 at Mimedx, up from $247.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $249.7 million in Q1 2026 to a low of -$18.8 million in Q4 2022.
• The 5-year median for Equity Average is $149.2 million (2024), against an average of $105.2 million.
• Across the five-year window, Equity Average sank 555.05% in 2022 and surged 3179.11% in 2024, its largest moves.
• Mimedx's Equity Average stood at -$18.8 million in 2022, then soared by 484.04% to $72.0 million in 2023, then surged by 159.72% to $187.1 million in 2024, then jumped by 32.44% to $247.7 million in 2025, then advanced by 0.81% to $249.7 million in 2026.
• The last three Equity Average figures came in at $249.7 million (Q1 2026), $247.7 million (Q4 2025), and $227.8 million (Q3 2025), per Business Quant data.